Rite Aid Corp. has expanded nonprescription access to naloxone, an opioid-overdose reversal drug, to four more states. Rite Aid said Tuesday that naloxone is now available without a prescription at more than 440 pharmacies in Kentucky, Ohio, Oregon and Vermont, subject to state regulations.
Perrigo Co. plc is bringing in methamphetamine-blocking capability for pseudoephedrine (PSE) products. On Tuesday, Perrigo said it has entered an exclusive licensing agreement with St. Louis-based Highland Pharmaceuticals for its Tarex meth-blocking technology.
Janssen Biotech Inc. has received Food and Drug Administration clearance for Stelara in treating Crohn’s disease in adults.
Endo International plc has appointed Paul Campanelli, as president and chief executive officer, succeeding Rajiv De Silva, who is stepping down. Endo said Campanelli, who was president of its generic drugs and OTC business, takes the helm as president and CEO effective immediately.
The upcoming enrollment period for the Affordable Care Act will be pivotal, as hikes in premiums, withdrawals by insurance companies and sign-ups that fell short of targets have combined to call the law’s sustainability into question.
Thrifty White Pharmacy has received specialty pharmacy accreditation from URAC, a health care standards organization. The regional drug chain said Friday that its central specialty pharmacy was awarded the designation from Washington, D.C.-based URAC.
Aurobindo Pharma Ltd. has gained tentative approval from the Food and Drug Administration for dolutegravir 50 mg, an HIV medication.
Shannon Strickland, a senior vice president for Fred’s Pharmacy, has been hired by Ateb Inc. as vice president of pharmacy execution. Ateb said Thursday that Strickland will lead its independent sales team and select pharmacy chains.
Janssen Pharmaceuticals Inc. has received approval from the Food and Drug Administration for Invokamet XR, a type 2 diabetes medication.
The Pharmaceutical Research and Manufacturers of America (PhRMA) yesterday brought more than 60 researchers and scientists from its member companies to meet with congressional lawmakers.
KVK Tech Inc. plans to release Lomaira tablets, a short-term, low-dose prescription medicine for weight loss, by the end of this month. KVK said Tuesday that Lomaira (phentermine hydrochloride 8-mg tablets CIV) gained approval from the Food and Drug Administration.
Emma Walmsley has been named to succeed Sir Andrew Witty as chief executive officer of GlaxoSmithKline plc. The drug maker said Tuesday that Walmsley, CEO of GSK Consumer Healthcare, is slated to take the reins from Witty when he retires on March 31, 2017. Plans call for her to become a member of
Amneal Pharmaceuticals LLC next month plans to begin shipping Yuvafem 10-mcg estradiol vaginal inserts, a treatment for menopausal symptoms. Amneal said Monday that its product represents the first generic equivalent of Vagifem from Novo Nordisk.
It’s now over a year that CVS Health launched its ScriptSync medication synchronization program, and for many participants the service has made a difference. CVS said Thursday that in the past year, more than 1 million patients have been enrolled in ScriptSync at CVS Pharmacy.
Allergan plc plans to buy clinical-stage biotech firm Vitae Pharmaceuticals Inc. in a cash deal valued at $639 million.
